PAX6 expression in the developing human eye
- Sachiko Nishinaa,
- Shinichi Kohsakab,
- Yuki Yamaguchic,
- Hiroshi Handac,
- Atsushi Kawakamid,
- Hajime Fujisawad,
- Noriyuki Azumaa
- aDepartment of Ophthalmology, National Children’s Hospital, Tokyo, Japan, bDepartment of Neurochemistry, National Institute of Neuroscience, Tokyo, Japan, cDepartment of Biomolecular Engineering, Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, Kanagawa, Japan, dDivision of Biological Science, Nagoya University Graduate School of Science, Nagoya, Japan
- Noriyuki Azuma, MD, Department of Ophthalmology, National Children’s Hospital, 3-35-31 Taishido, Setagaya-ku, Tokyo, 154-8509, Japan.
- Accepted 11 January 1999
Abstract
AIMS To investigate the changes in PAX6 expression in the developing human eye.
METHODS Six developing human eyes from 6 to 22 weeks’ gestation were evaluated. Frozen sections were immunohistochemically stained with monoclonal antibody to chick Pax6 (amino acids 1–223). To verify antibody specificity, western blot analysis was carried out using cell lysates from P19 cells transfected with the human PAX6 gene.
RESULTS Western blot analysis demonstrated that the antibody reacted to human PAX6 protein. Positive immunostainings for PAX6 were seen in the surface ectoderm, lens vesicle, inner and outer layers of the optic cup, and optic stalk at 6 weeks, and in the corneal epithelia and conjunctiva, lens, and non-pigmented ciliary epithelia from 8 to 22 weeks. In the retina, positive cells were seen in the entire retina from 8 to 10 weeks, and were restricted to the ganglion cell layer and the inner and outer portions of the inner nuclear layer after 21 weeks.
CONCLUSIONS PAX6 is expressed on the surface and neuroectoderms at an early stage, then in the differentiating cells in the cornea, lens, ciliary body, and retina through development. PAX6 may play a role in determining cell fate in the morphogenesis of various human ocular tissue.
